Current Studies

Our Commitment to Research

At Lilli Health, we are deeply committed to advancing research that drives our mission of transforming the way patients are monitored and managed for insulin resistance. Our ongoing studies focus on establishing insulin testing as a critical component of care and promoting the Low Insulin Lifestyle as the standard of treatment for patients with insulin resistance and PCOS. We believe that through evidence-based research, we can create a lasting impact in improving patient outcomes and ensuring that each individual receives proactive, effective care.

Interested in participating in one of our research studies? Click the link below to learn more or reach out to us at research@lillihealth.com.

Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Currently Recruiting

This study (NCT05950282) aims to explore how fasting insulin levels and insulin resistance (measured by HOMA-IR) vary across different demographic and clinical factors. Specifically, this study examines the relationships between insulin resistance and factors like age, sex, race/ethnicity, body mass index (BMI), and a PCOS diagnosis.

Through this research, we hope to identify patterns and disparities in insulin resistance across these groups. The insights gained from this study could help us better understand how metabolic health conditions develop and provide more targeted approaches for managing insulin resistance and related conditions. This observational study is essential to our commitment to advancing care for insulin resistance and supporting personalized, evidence-based treatment.

For more information or to participate, please reach out to us at research@lillihealth.com.

Effectiveness of the Lilli App in Treating Insulin Resistance in Patients with PCOS (LILLI)

Not Yet Recruiting

The LILLI study aims to evaluate whether following a Low Insulin Lifestyle, guided by the Lilli app, can improve insulin resistance in patients with PCOS over 8 weeks. Through lifestyle support focused on lowering insulin levels, the study will track key markers (HOMA-IR and Matsuda Index) to assess insulin sensitivity before and after the 8-week intervention. Women with PCOS of various body types will be recruited through social media and healthcare providers to ensure a diverse participant group. The goal is to see if the Lilli app can support better metabolic and hormonal health for patients with PCOS.

For more information or to participate, please reach out to us at research@lillihealth.com.